Asia-Pacific Genetic Testing Market Share

Statistics for the 2023 & 2024 Asia-Pacific Genetic Testing market share, created by Mordor Intelligence™ Industry Reports. Asia-Pacific Genetic Testing share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Asia-Pacific Genetic Testing Industry

The Asia-Pacific genetic testing market is highly competitive and consists of several major players. In terms of market share, a few major players currently dominate the market. However, with technological advancement and product innovation, mid-size to smaller companies are increasing their market presence by introducing new ingredients at lower prices. Companies like Abbott Laboratories Inc., Bio-Rad Laboratories Inc., Myriad Genetics Inc., Genomic Health Inc., and Mapmygenome hold the substantial market share in the Asia-Pacific genetic testing market.

Asia Pacific Genetic Testing Market Leaders

  1. Abbott Laboratories

  2. Bio-Rad Laboratories Inc.

  3. Myriad Genetics, Inc.

  4. Genomic Health Inc.

  5. Mapmygenome

*Disclaimer: Major Players sorted in no particular order

Asia-Pacific Gen

Asia Pacific Genetic Testing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)